Jim Wassil - 01 Jul 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Reporting relationship: CHIEF OPERATING OFFICER
Issuer ticker: PCVX
Reported as of: 01 Jul 2026
Net transaction value: -$126,736
SEC form: 4
Accepted by SEC: 06 Jul 2026, 18:25:54 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact

Key filing fact

Jim Wassil filed Form 4 for Vaxcyte, Inc. (PCVX) on 06 Jul 2026.

Key facts

This page summarizes Jim Wassil's Form 4 filing for Vaxcyte, Inc. (PCVX).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jul 2026, 18:25.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: -$126,736.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001813798 Primary reporting owner

Wassil Jim

Relationship: CHIEF OPERATING OFFICER
Address: C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS
Signature: Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Options Exercise

Transaction value
Shares: +516
Change %: +0.33%
Price: $5.35^*
Shares after: 159,010
Date: 01 Jul 2026
Ownership: Direct

PCVX transaction

Common Stock

Sale

Transaction value: $100,182
Shares: -1,788
Change %: -1.1%
Price: $56.03
Shares after: 157,222
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F2

PCVX transaction

Common Stock

Sale

Transaction value: $26,208
Shares: -456
Change %: -0.29%
Price: $57.47
Shares after: 156,766
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F3

PCVX transaction

Common Stock

Sale

Transaction value: $347
Shares: -6
Change %: -0%
Price: $57.82
Shares after: 156,760
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCVX transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -516
Change %: -0.72%
Price: $0.000000^*
Shares after: 71,148
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 516
Exercise price: $5.35
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.

Footnote F2

The price reported is a weighted-average price. The shares were sold at prices ranging from $55.60 to $56.595. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

The price reported is a weighted-average price. The shares were sold at prices ranging from $56.695 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F4

Stock Option is fully vested and exercisable.